TPX-100: OrthoTrophix Presents New Data Revealing Structural Coupling between Femoral Bone Shape and Meniscal Pathology in Knee Osteoarthritis
FOSTER CITY, Calif., April 24, 2026 /PRNewswire/ -- OrthoTrophix, Inc., a privately held biopharmaceutical company, today announced new clinical data...
Read moreDetails